Amgen Inc.

Ticker

AMGN

ISIN

US0311621009

Price

-

Change Today

-

Price 1 year ago

-

Market Capitalization

149,761,163,264.00


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Sector

Healthcare

Industry

Drug Manufacturers—General

Country

United States

Exchange

NMS

Earnings Per Share

12.073

P/E Ratio

22.022696

Debt/Equity Ratio

4023.362

Beta

0.581524

City

Thousand Oaks

Address

One Amgen Center Drive

Zip

91320-1799

Ebitda

12,892,000,256.00

Ebitda Margins

0.49

Enterprise to Ebitda

12.61

Enterprise Value

162,508,455,936.00

Target Price

-

Estimated Price

176.62

Book Value

16.23

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE -0.215
600867.SS TONGHUA DONGBAO MEDICINES CO LT -0.002
2186.HK LUYE PHARMA 0.017
KLBF.JK Kalbe Farma Tbk. 0.058
300006.SZ CHONGQING LUMMY PH 0.090
600276.SS JIANGSU HENGRUI MEDICAL CO LTD 0.091
4568.T DAIICHI SANKYO COMPANY LIMITED 0.117
4519.T CHUGAI PHARMACEUTICAL CO 0.157
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI 0.159
600713.SS NANJING PHARMACEUTICAL CO LTD 0.179
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C 0.219
4503.T ASTELLAS PHARMA 0.220
HZNP Horizon Therapeutics Public Lim 0.226
ECILC.IS ECZACIBASI ILAC 0.283
1093.HK CSPC PHARMA 0.344
PFE Pfizer, Inc. 0.362
MYX.AX M PHARMA FPO 0.371
600613.SS SHANGHAI SHENQI PHARM INVEST MA 0.379
LLY Eli Lilly and Company 0.379
GSK.L GSK PLC 0.416
AZN Astrazeneca PLC 0.452
ABBV AbbVie Inc. 0.463
GSK GSK plc 0.533
SNY Sanofi 0.564
BMY Bristol-Myers Squibb Company 0.600
GILD Gilead Sciences, Inc. 0.633
JNJ Johnson & Johnson 0.655
MRK Merck & Company, Inc. 0.657
NOVN.SW NOVARTIS N 0.689

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
600276.SS JIANGSU HENGRUI MEDICAL CO LTD Lianyungang China CNY SHH 58.730 24491 https://www.hrs.com.cn
KLBF.JK Kalbe Farma Tbk. Jakarta Indonesia IDR JKT 0.500 14.499 12392 https://www.kalbe.co.id
1093.HK CSPC PHARMA Shijiazhuang China HKD HKG 0.669 12.860 24746 https://www.cspc.com.hk
300006.SZ CHONGQING LUMMY PH Chongqing China CNY SHZ 0.826 -32.334 935 https://www.cqlummy.com
PFE Pfizer, Inc. New York United States USD NYQ 0.679 6.878 79000 https://www.pfizer.com
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C Hangzhou China CNY SHH 0.458 10.685 8589 https://www.conbagroup.com
600713.SS NANJING PHARMACEUTICAL CO LTD Nanjing China CNY SHH 0.458 9.366 5062 https://www.njyy.com
600867.SS TONGHUA DONGBAO MEDICINES CO LT Tonghua China CNY SHH 0.237 12.421 https://www.thdb.com
ECILC.IS ECZACIBASI ILAC Istanbul Turkey TRY IST 0.202 71.703 336 https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services
GSK.L GSK PLC Brentford United Kingdom GBp LSE 0.323 6.217 90096 https://www.gsk.com
MRK Merck & Company, Inc. Kenilworth United States USD NYQ 0.355 10.372 67000 https://www.merck.com
BMY Bristol-Myers Squibb Company New York United States USD NYQ 0.442 8.866 32200 https://www.bms.com
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI Xi'an China CNY SHH 0.546 -48.110 1900 https://www.guangyuyuan.com
GILD Gilead Sciences, Inc. Foster City United States USD NMS 0.391 7.192 14400 https://www.gilead.com
JNJ Johnson & Johnson New Brunswick United States USD NYQ 0.568 14.446 141700 https://www.jnj.com
GSK GSK plc Brentford United Kingdom USD NYQ 0.184 8.076 90096 https://www.gsk.com
AZN Astrazeneca PLC Cambridge United Kingdom USD NMS 0.119 18.553 83100 https://www.astrazeneca.com
ABBV AbbVie Inc. North Chicago United States USD NYQ 0.749 11.461 50000 https://www.abbvie.com
2186.HK LUYE PHARMA Yantai China HKD HKG 0.747 14.061 4845 https://www.luye.cn
600613.SS SHANGHAI SHENQI PHARM INVEST MA Shanghai China CNY SHH 0.359 22.962 1371 https://www.gzsq.com
MYX.AX M PHARMA FPO Salisbury South Australia AUD ASX 1.088 27.982 https://www.maynepharma.com
4568.T DAIICHI SANKYO COMPANY LIMITED Tokyo Japan JPY JPX 52.122 16458 https://www.daiichisankyo.com
4503.T ASTELLAS PHARMA Tokyo Japan JPY JPX 0.582 12.390 14522 https://www.astellas.com
NOVN.SW NOVARTIS N Basel Switzerland CHF EBS 0.498 10.304 108000 https://www.novartis.com
SNY Sanofi Paris France USD NMS 0.363 9.753 95442 https://www.sanofi.com
HZNP Horizon Therapeutics Public Lim Dublin Ireland USD NMS 1.157 20.666 1940 https://www.horizontherapeutics.com
LLY Eli Lilly and Company Indianapolis United States USD NYQ 0.367 28.997 35000 https://www.lilly.com
AMGN Amgen Inc. Thousand Oaks United States USD NMS 0.582 12.605 24200 https://www.amgen.com
4519.T CHUGAI PHARMACEUTICAL CO Tokyo Japan JPY JPX 0.635 9.600 7664 https://www.chugai-pharm.co.jp
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE Zhangzhou China CNY SHH 0.777 57.527 2591 https://www.zzpzh.com.cn
BAYN.DE BAYER AG Leverkusen Germany EUR GER 1.160 13.665 101914 https://www.bayer.com
AZN.L ASTRAZENECA PLC ORD SHS $0.25 Cambridge United Kingdom GBp LSE 0.097 15.964 83100 https://www.astrazeneca.com
300357.SZ ZHEJIANG WOLWO BIO Huzhou China CNY SHZ 0.403 56.571 1488 https://www.wolwobiotech.com
SAN.PA SANOFI Paris France EUR PAR 0.356 9.863 95442 https://www.sanofi.com
NVS Novartis AG Basel Switzerland USD NYQ 0.488 10.621 108000 https://www.novartis.com
0P6S.IL BAYER AG Leverkusen Germany EUR IOB 1.148 9.508 100753 https://www.bayer.com
CIPLA.NS CIPLA LTD Mumbai India INR NSI 17.912 https://www.cipla.com
4528.T ONO PHARMACEUTICAL CO Osaka Japan JPY JPX 0.332 13.404 3687 https://www.ono-pharma.com
4536.T SANTEN PHARMACEUTICAL CO Osaka Japan JPY JPX 0.375 7.050 4315 https://www.santen.com
OGN Organon & Co. Jersey City United States USD NYQ 7.831 9300 https://www.organon.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.